Page 4 - Australian (ASX) Growth Pharmaceuticals & Biotech Stocks
UPDATED Apr 09, 2026
Discover Australian Pharmaceuticals & Biotech Growth Stocks that are on the ASX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
79 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
FRE | AU$0.057 | 7.5% | -28.7% | AU$14.4m | n/a | 35.0 | n/a | n/a | ||
ANR | AU$0.01 | 11.1% | 66.7% | AU$3.2m | n/a | 5.1 | n/a | n/a | ||
VLS | AU$2.59 | 3.2% | 43.1% | AU$140.9m | n/a | 13.5 | n/a | 5.4% | ||
GTG | AU$0.039 | 0% | -68.8% | AU$5.7m | n/a | 3.1 | n/a | n/a | ||
PAB | AU$0.025 | -7.4% | 4.2% | AU$13.4m | n/a | 133.3 | n/a | n/a | ||
BDX | AU$0.092 | -7.1% | 3.4% | AU$33.9m | n/a | 13.4 | n/a | n/a | ||
BXN | AU$0.066 | 3.1% | 175.0% | AU$149.8m | n/a | 16.8 | n/a | n/a |